Anti‐IL‐4Rα mAb (dupilumab) vs placebo (on top of topical steroids)
Disease severity ‐ VAS (range 0 to 10, lower = better) · patients with severe chronic rhinosinusitis with nasal polyps
1 finding from 1 review
- no estimate extracted3 studies · 784 participantsModerate